AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15352664 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored group (n = 67)
Number of subjects: 112
Study 15352664 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 112
Study 11259226 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard services plus extra training for foster carers on communication and attachment
Number of subjects: 182
Study 11259226 — intervention group
Group type: COMPARATOR
Intervention: Standard services alone
Number of subjects: 182
Study 9277243 — intervention group
Group type: EXPERIMENTAL
Intervention: Current Important Message from Medicare
Number of subjects: 0
Study 9277243 — intervention group
Group type: COMPARATOR
Intervention: Alternatives for informing beneficiaries of their rights
Number of subjects: 0
Study 7838460 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid
Number of subjects: 60
Study 7838460 — intervention group
Group type: COMPARATOR
Intervention: Diclophenac sodium
Number of subjects: 60
Study 3277398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic treatment of mild-to-moderate hypertension
Number of subjects: 34000
Study 31719052 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release oral morphine
Number of subjects: 279
Study 31719052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study 31124516 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar block with 0.5% ropivacaine plus dexmedetomidine 1 μg/kg (group RD, n = 20)
Number of subjects: 60
Study 31124516 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar block with 0.5% ropivacaine (group RB, n = 20)
Number of subjects: 60
Study 31124516 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (group F, n = 20)
Number of subjects: 60
Study 28277409 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine povacrylex-alcohol (IPA)
Number of subjects: 788
Study 28277409 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine-alcohol
Number of subjects: 788
Study 27146668 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF application at the donor site
Number of subjects: 43
Study 27146668 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRGF application)
Number of subjects: 43
Study 23398551 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention plus standard care
Number of subjects: 0
Study 23398551 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 0
Study 22108483 — intervention group
Group type: EXPERIMENTAL
Intervention: Acustop
Number of subjects: 42
Study 22108483 — intervention group
Group type: COMPARATOR
Intervention: Control (follow-up only)
Number of subjects: 42
Study 19250113 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced magnetic resonance imaging (CMR)
Number of subjects: 24
Study 19250113 — intervention group
Group type: COMPARATOR
Intervention: (99m)Tc‐2‐methoxy isobutyl isonitrile single photon emission computed tomography (SPECT)
Number of subjects: 24
Study 19250113 — intervention group
Group type: COMPARATOR
Intervention: SPECT
Number of subjects: 24
Study 19250113 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR
Number of subjects: 24
Study 16709204 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micrograms of oral misoprostol
Number of subjects: 0
Study 16709204 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 micrograms of oral misoprostol
Number of subjects: 0
Study 16709204 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micrograms of vaginal misoprostol
Number of subjects: 0
Study 16709204 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 14750007 — intervention group
Group type: EXPERIMENTAL
Intervention: Force-velocity test (F-V)
Number of subjects: 19
Study 14750007 — intervention group
Group type: EXPERIMENTAL
Intervention: Wingate test
Number of subjects: 19
Study 14750007 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral temperature measurement
Number of subjects: 19
Study 11728919 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of oral alendronate
Number of subjects: 100
Study 11728919 — intervention group
Group type: COMPARATOR
Intervention: Placebo (with 500 mg of calcium in the form of daily calcium carbonate)
Number of subjects: 100
Study 9155502 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise
Number of subjects: 11
Study 9155502 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise
Number of subjects: 11
Study 9155502 — intervention group
Group type: COMPARATOR
Intervention: Control session
Number of subjects: 11
Study 8190388 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 0
Study 8190388 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 0
Study 3069206 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg daily for the first 3 months)
Number of subjects: 1395
Study 3069206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1395
Study 29494417 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose vitamin D3 (100,000 IU), n = 2041
Number of subjects: 5108
Study 29494417 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 2014
Number of subjects: 5108
Study 29494417 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose vitamin D3 (100,000 IU), n = 559 (21.9%)
Number of subjects: 5108
Study 29494417 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 593 (23.3%)
Number of subjects: 5108
Study 29494417 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose vitamin D3 (100,000 IU)
Number of subjects: 5108
Study 29494417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5108
Study 29494417 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose vitamin D3 (100,000 IU) in vitamin D deficient participants (<50 nmol/L, 24.9%)
Number of subjects: 5108
Study 29494417 — intervention group
Group type: COMPARATOR
Intervention: Placebo in vitamin D deficient participants
Number of subjects: 5108
Study 26473755 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 126
Study 26473755 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 126
Study 24942404 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2603618 (130-275 mg) in combination with pemetrexed (500 mg/m²) and cisplatin (75 mg/m²)
Number of subjects: 14
Study 24942404 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2603618 (≥240 mg) in combination with pemetrexed (500 mg/m²) and cisplatin (75 mg/m²)
Number of subjects: 14
Study 22142410 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Amino Acid Supplementation (AAS)
Number of subjects: 155
Study 22142410 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 155
Study 22142410 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino Acid Supplementation (AAS)
Number of subjects: 155
Study 22142410 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 155
Study 20061070 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurolidine
Number of subjects: 30
Study 20061070 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 30
Study 18439948 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir plus prednisone
Number of subjects: 91
Study 18439948 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 91
Study 16652039 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 3234
Study 16652039 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions with motivational and skills components
Number of subjects: 3234
Study 12631138 — intervention group
Group type: COMPARATOR
Intervention: Four hours of hemodialysis (SD)
Number of subjects: 8
Study 12631138 — intervention group
Group type: COMPARATOR
Intervention: Eight hours of hemodialysis
Number of subjects: 8
Study 12631138 — intervention group
Group type: COMPARATOR
Intervention: Eight hours of hemodialysis using a smaller dialyzer and slower blood pump
Number of subjects: 8
Study 11040164 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (3-day course)
Number of subjects: 248
Study 11040164 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 248
Study 8617710 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol plus sertraline (200 mg/day)
Number of subjects: 24
Study 8617710 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (2 mg)
Number of subjects: 24
Study 8617710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8617710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 to 200 mg/day)
Number of subjects: 24
Study 8500374 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-term high-dose irradiation (25.5 Gy in one week)
Number of subjects: 471
Study 8500374 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy (60 Gy in seven to eight weeks)
Number of subjects: 471
Study 8500374 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 471
Study 8500374 — intervention group
Group type: COMPARATOR
Intervention: Postoperative irradiation
Number of subjects: 471
Study 8500374 — intervention group
Group type: COMPARATOR
Intervention: Nonirradiated patients
Number of subjects: 471
Study 3552697 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol salt (FT)
Number of subjects: 675
Study 3552697 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (AMX)
Number of subjects: 675
Study 3552697 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (CTX)
Number of subjects: 675
Study 29704966 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention, consisting of four 2.5-hour workshops over a 4-week period, with home exercises (e.g., meditation, observation grids)
Number of subjects: 144
Study 29704966 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention
Number of subjects: 144
Study 29704966 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 144
Study 27778333 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing Home Compare Plus (NHCPlus)
Number of subjects: 225
Study 25274787 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation protocol
Number of subjects: 81
Study 25274787 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation protocol
Number of subjects: 81
Study 23269680 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab plus ablative therapy
Number of subjects: 20
Study 23269680 — intervention group
Group type: COMPARATOR
Intervention: Ablative therapy alone
Number of subjects: 20
Study 21381350 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopheron
Number of subjects: 30
Study 21381350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17909829 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted partial tonsillectomy (group 1)
Number of subjects: 143
Study 17909829 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery-assisted total tonsillectomy (group 2)
Number of subjects: 143
Study 15758000 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300-mg loading dose, followed by 75 mg once daily)
Number of subjects: 3491
Study 15758000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3491
Study 15758000 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 3491
Study 12753270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride
Number of subjects: 0
Study 12753270 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 0
Study 12858934 — intervention group
Group type: EXPERIMENTAL
Intervention: Daycare hernia repair (61 patients)
Number of subjects: 121
Study 12858934 — intervention group
Group type: COMPARATOR
Intervention: Inpatient hernia repair (60 patients)
Number of subjects: 121
Study 8795597 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 23
Study 8795597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 1630347 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebuhaler/MDI (metered dose aerosol terbutaline)
Number of subjects: 61
Study 1630347 — intervention group
Group type: COMPARATOR
Intervention: Nebulised wet aerosol terbutaline
Number of subjects: 61
Study 3934548 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 0
Study 3934548 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum combined with behavioral treatment
Number of subjects: 0
Study 3934548 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 0
Study 30615055 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls prevention exercise programme based on the Otago Exercise Programme (OEP)
Number of subjects: 155
Study 30615055 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 155
Study 29873076 — intervention group
Group type: EXPERIMENTAL
Intervention: Low mast cell density (MCD)
Number of subjects: 854
Study 27494722 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 60
Study 27494722 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 60
Study 25054836 — intervention group
Group type: EXPERIMENTAL
Intervention: Active gamma ventral capsulotomy (GVC)
Number of subjects: 16
Study 25054836 — intervention group
Group type: COMPARATOR
Intervention: Sham GVC
Number of subjects: 16
Study 25054836 — intervention group
Group type: COMPARATOR
Intervention: Sham GVC followed by active GVC
Number of subjects: 16
Study 22517385 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic splinting
Number of subjects: 66
Study 22517385 — intervention group
Group type: COMPARATOR
Intervention: Static splinting
Number of subjects: 66
Study 20355244 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (CRT)
Number of subjects: 238
Study 20355244 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemoradiotherapy (CRT)
Number of subjects: 238
Study 20355244 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 238
Study 20355244 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative CRT
Number of subjects: 238
Study 20355244 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative CRT
Number of subjects: 238
Study 20355244 — intervention group
Group type: EXPERIMENTAL
Intervention: Local recurrence rates
Number of subjects: 238
Study 18584466 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 mg nicotine patches
Number of subjects: 56
Study 18584466 — intervention group
Group type: COMPARATOR
Intervention: placebo patches
Number of subjects: 56
Study 16110845 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment
Number of subjects: 21
Study 11756072 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy protein (ISP) containing 56 mg isoflavones (ISP56)
Number of subjects: 73
Study 11756072 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy protein (ISP) containing 90 mg isoflavones (ISP90)
Number of subjects: 73
Study 11756072 — intervention group
Group type: COMPARATOR
Intervention: Control (casein from nonfat dry milk)
Number of subjects: 73
Study 10081993 — intervention group
Group type: COMPARATOR
Intervention: Low-dose IVAA (125 mg protein/kg/h)
Number of subjects: 6
Study 10081993 — intervention group
Group type: COMPARATOR
Intervention: High-dose IVAA (250 mg protein/kg/h)
Number of subjects: 6
Study 10081993 — intervention group
Group type: COMPARATOR
Intervention: i.v. saline (control)
Number of subjects: 6
Study 8585105 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 54
Study 2210608 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 40 mg (q.i.d.)
Number of subjects: 129
Study 2210608 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg (b.i.d.)
Number of subjects: 129
Study 2210608 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 1600 mg (q.i.d.)
Number of subjects: 129
Study 2210608 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 800 mg (b.i.d.)
Number of subjects: 129
Study 508701 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 500 mg/d
Number of subjects: 0
Study 508701 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium caseinate 15 g/d
Number of subjects: 0
Study 31987544 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb Robot‐assisted Therapy (RT)
Number of subjects: 48
Study 31987544 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical Therapy (TT)
Number of subjects: 48
Study 30244073 — intervention group
Group type: COMPARATOR
Intervention: No CE and no ICAS
Number of subjects: 140
Study 30244073 — intervention group
Group type: COMPARATOR
Intervention: ICAS without CE
Number of subjects: 140
Study 30244073 — intervention group
Group type: COMPARATOR
Intervention: CE without ICAS
Number of subjects: 140
Study 30244073 — intervention group
Group type: COMPARATOR
Intervention: CE and ICAS
Number of subjects: 140
Study 27916241 — intervention group
Group type: EXPERIMENTAL
Intervention: No-touch technique (group NT)
Number of subjects: 368
Study 27916241 — intervention group
Group type: COMPARATOR
Intervention: Minimal manipulation technique (group MM)
Number of subjects: 368
Study 25886875 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based exposure and response prevention (MB-ERP)
Number of subjects: 40
Study 25886875 — intervention group
Group type: COMPARATOR
Intervention: Exposure and response prevention (ERP)
Number of subjects: 40
Study 23748448 — intervention group
Group type: EXPERIMENTAL
Intervention: High-alcohol mouthwash
Number of subjects: 50
Study 23748448 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-alcohol mouthwash
Number of subjects: 50
Study 23748448 — intervention group
Group type: COMPARATOR
Intervention: Negative control mouthwash
Number of subjects: 50
Study 23748448 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinkers
Number of subjects: 50
Study 23748448 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondrinkers rinsing with high-alcohol mouthwash
Number of subjects: 50
Study 21385432 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic teaching and self‐directed learning (DT/SDL)
Number of subjects: 205
Study 21385432 — intervention group
Group type: COMPARATOR
Intervention: Didactic teaching (DT)
Number of subjects: 205
Study 19302904 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance device with grass allergen tablets
Number of subjects: 91
Study 17391286 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous confidence intervals for several designs and aims in clinical trials
Number of subjects: 0
Study 17391286 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous confidence intervals for the difference or the ratio
Number of subjects: 0
Study 17391286 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous intervals for dose-finding trials
Number of subjects: 0
Study 17391286 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional testing of all hypotheses at level alpha
Number of subjects: 0
Study 17391286 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion of other multiplicity issues
Number of subjects: 0
Study 15492300 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (3 g at least 2 hours before the procedure and 2 g in the night and the morning after the procedure)
Number of subjects: 231
Study 15492300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 15492300 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 231
Study 11235926 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5, 10, or 15 mg/day)
Number of subjects: 206
Study 11235926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 11235926 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 206
Study 9744770 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-thioguanine (6TG)
Number of subjects: 73
Study 9744770 — intervention group
Group type: COMPARATOR
Intervention: 6-mercaptopurine (6MP)
Number of subjects: 73
Study 7921452 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency chest compression (HFCC)
Number of subjects: 50
Study 7921452 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (CPT)
Number of subjects: 50
Study 3057997 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer of pronuclear embryos (day 1)
Number of subjects: 0
Study 3057997 — intervention group
Group type: COMPARATOR
Intervention: Transfer of cleavage embryos (day 2)
Number of subjects: 0
Study 1134717 — intervention group
Group type: COMPARATOR
Intervention: Scheie's procedure
Number of subjects: 71
Study 1134717 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with a sutured scleral flap
Number of subjects: 71
Study 1134717 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 71
Study 1134717 — intervention group
Group type: COMPARATOR
Intervention: Scheie's procedure and Trabeculectomy
Number of subjects: 71
Study 31939321 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster nursing measures in combination with continuous phototherapy (blue light)
Number of subjects: 141
Study 31939321 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing together with continuous phototherapy (blue light)
Number of subjects: 141
Study 30419153 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE)
Number of subjects: 22
Study 28576897 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep intervention (antenatal education session and home visit at 3 weeks postpartum)
Number of subjects: 802
Study 28576897 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 802
Study 28576897 — intervention group
Group type: EXPERIMENTAL
Intervention: FAB and combination groups (food, activity and breastfeeding intervention)
Number of subjects: 802
Study 25942417 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium-based contrast agent (GBCA)
Number of subjects: 10